Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546439 · ClinicalTrials.gov registry record
VAscular Closure for Cardiac Ablation Registry (VACCAR)
A clinical trial, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- 434
- Enrollment target
NCT03546439: Completed study, sponsored by Saint Luke's Health System.
NCT03546439 is a clinical trial that has completed, run by Saint Luke's Health System. The registered enrollment target is 434 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03546439 has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- 434 participants
- Enrollment target
Study Summary
The objective of this registry is to find out if there is a difference in patient satisfaction and rate of vascular and bleeding complications with use of Perclose Proglide system or F08S for venous closure post atrial fibrillation and atrial flutter procedures in comparison to manual compression.
Primary Outcome
Time to achieve hemostasis measured in minutes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 2017-10-25 |
| Est. Completion | 2019-05-24 |
What the finished NCT03546439 record still lists
NCT03546439 is an observational study that tracks outcomes without assigning an intervention. The registered 434 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03546439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03546439 about?
NCT03546439 is a clinical study titled "VAscular Closure for Cardiac Ablation Registry (VACCAR)". The objective of this registry is to find out if there is a difference in patient satisfaction and rate of vascular and bleeding complications with use of Perclose Proglide system or F08S for venous closure post atrial fibrillation and atrial flutter procedures in comparison to manual compression.
What is the current status of trial NCT03546439?
This trial is currently completed. The enrollment target is 434 participants. The study started on 2017-10-25. Estimated completion is 2019-05-24.
Who is sponsoring clinical trial NCT03546439?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI